1. H. Lundbeck A/s (29 from 506 patents)

2. Cephalon, Inc. (2 from 247 patents)

3. Other (1 from 832,680 patents)

4. H. Lunbeck A/s (1 from 4 patents)

5. Bioei Therapies Corp (1 from 1 patent)

6. Biotie Therapies Corporation (28 patents)

1. 12421271 - Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

2. 12152029 - Crystalline forms of a MAGL inhibitor

3. 11858954 - Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

4. 11458134 - 1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

5. 11279682 - Vortioxetine pyroglutamate

6. 11130775 - Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

7. 10857149 - Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazine

8. 10287261 - Vortioxetine pyroglutamate

9. 10071963 - Polymorphic form of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of Alzheimer's disease

10. 10034876 - Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazine

11. 9938286 - Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption

12. 9861630 - [object Object]

13. 9725458 - Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption

14. 9475748 - Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

15. 9315459 - Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine